High Leverage / Balance Sheet ConstraintDebt-to-equity resumed >2.0x after prior improvement, leaving the balance sheet relatively levered versus equity. Elevated leverage limits financial flexibility, increases refinancing and covenant sensitivity, and constrains the company's ability to self-fund larger organic or M&A opportunities without additional external financing over the medium term.
Net Losses And Earnings VolatilityDespite stronger operating profitability, the company is still slightly net unprofitable and experienced a large prior loss in 2024, indicating earnings volatility. Persistent bottom-line losses reduce retained earnings and the predictability of distributable cash, complicating plans for sustainable shareholder returns and conservative capital allocation.
Modest Free Cash Flow & Execution/funding Risk For GrowthFree cash flow is modest relative to the scale of planned expansions and management’s >$100M organic EBITDA goal to 2030. The Double E buildout still needs further commercial commitments to reach FID, creating execution and funding risk that may force reliance on revolver draws, refinancings or equity, eroding long-term returns if not managed.